NERV
Minerva Neurosciences Inc
NASDAQ: NERV · HEALTHCARE · BIOTECHNOLOGY
$6.47
+1.25% today
Updated 2026-04-30
Market cap
$281.90M
P/E ratio
—
P/S ratio
1.87x
EPS (TTM)
$-34.67
Dividend yield
—
52W range
$1 – $9
Volume
0.3M
Minerva Neurosciences Inc (NERV) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |